Abstract 3280: Type I IFN receptor signaling in myeloid and T cells drives antitumor immunity elicited by intratumoral delivery of immunogenic recombinant modified vaccinia virus Ankara

Yueqi Wang(Memorial Sloan Kettering Cancer Center), Liang Deng(Memorial Sloan Kettering Cancer Center), Ping Chi(Memorial Sloan Kettering Cancer Center), Charles M. Rice(Rockefeller University), Shanza Baseer Tariq(Memorial Sloan Kettering Cancer Center), Zeda Zhang(Memorial Sloan Kettering Cancer Center), Jenny Xiang(Cornell University), Ning Yang(Memorial Sloan Kettering Cancer Center), Ming O. Li(Memorial Sloan Kettering Cancer Center), Gregory Mazo(Memorial Sloan Kettering Cancer Center), Juan C. Osorio(Laboratory of Molecular Genetics), Bharath Salla(Memorial Sloan Kettering Cancer Center), Yi Wang(University of Science and Technology of China), Weiyi Wang(Shanghai Jiao Tong University), Tuo Zhang(Cornell University), Scott Lowe(Memorial Sloan Kettering Cancer Center), Juan Yan(Memorial Sloan Kettering Cancer Center), Jeffrey V. Ravetch(National Institutes of Health), Jiahu Wang, Juan Angelo-Lozano(Rockefeller University), Shuaitong Liu(Memorial Sloan Kettering Cancer Center)
Cancer Research
April 21, 2025
Cited by 0


Related Papers